Methods and devices for encapsulating cells

US9587213B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9587213-B2
Application numberUS-201313749267-A
CountryUS
Kind codeB2
Filing dateJan 24, 2013
Priority dateJan 24, 2006
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Molds for making cell aggregation devices include upper and lower surfaces. Methods of aggregating cells include depositing cells on in a seeding chamber, incubating the cells and removing aggregated cells. Devices for encapsulating aggregates of cells include biocompatible, bio-sustainable substrates compartments and a coating of a biocompatible, bio-sustainable polymer that completely surrounds the substrate and cell-encapsulating compartments.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of aggregating cells, comprising the steps of: a) depositing a plurality of cells into an upper cell suspension seeding chamber of a cell aggregation device having a biocompatible, polymeric hydrogel substrate that includes an upper surface and a lower surface and having at least one compartment at least partially recessed into the upper surface, the compartment being composed of the upper cell suspension seeding chamber, at least one lower cell aggregation recess and a port extending there between, the upper cell suspension seeding chamber being formed and positioned to funnel cells into the lower cell aggregation recess via the port through gravitational force and the lower cell aggregation recess being composed of a cell-repellant hydrogel and being formed and positioned to coalesce the cells into a finite region of minimum gravitational energy; and b) incubating the cells for time sufficient to allow the cells to be funneled from the upper cell seeding chamber to the lower cell aggregation recess by gravity through the port and into the finite region; and c) incubating the cells for a time sufficient to allow the cells to aggregate in the finite region of the lower cell aggregation recess. 2. The method of claim 1 , further comprising the step of adding a selected aggregation modifying agent to the cells during the time sufficient to allow the cells to aggregate in the finite region of the lower cell aggregation recess. 3. The method of claim 1 , wherein said cells are selected from the group consisting of osteoblasts, keratinocytes, melanocytes, hepatocytes, gliacytes, pancreatic beta cells, pancreatic exocrine cells, neural stem cells, neural precursor cells, spinal cord precursor cells, nerve cells, mammary gland cells, salivary gland cells, renal glomerular endothelial cells, tubular epithelial cells, adrenocortical and adrenomedullary cells, cardiomyocytes, chondrocytes, skeletal and smooth muscle cells, fat and fat precursor cells, corneal and crystalline lens cells, embryonic retina cells, vascular cells, endothelial cells, bone marrow stromal cells, lymphocytes, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, connective tissue cells, epithelial cells, nervous system cells and nonhuman embryonic stem cells, non-embryonic and hematopoietic mammalian stem cells. 4. The method of claim 3 , wherein the connective tissue cells are at least one member selected from the group consisting of a fibroblast, a monocyte, a mast cell, a granulocyte, a plasma cell, an osteoclast, an osteocyte and a chondrocyte. 5. The method of claim 3 , wherein the epithelial cells at least one member selected from the group consisting of a skin epithelial cell, a gastrointestinal epithelial cell, a urinary tract epithelial cell, a reproductive tract epithelial cell, a liver epithelial cell, a pancreas epithelial cell, and a spleen epithelial cell. 6. The method of claim 3 , wherein the nervous system cell is at least one member selected from the group consisting of a glial cell, a neuronal cell and an astrocytes. 7. The method of claim 1 , further including the step of removing the aggregated cells from the lower aggregation recess.

Assignees

Inventors

Classifications

  • C12N5/0012Primary

    Cell encapsulation · CPC title

  • Particles; Beads; Granular material; Encapsulation (chemical or physical processes conducted in the presence of fluids and solid particles B01J8/00) · CPC title

  • Well or multiwell plates (C12M25/04 takes precedence) · CPC title

  • General methods for three-dimensional culture · CPC title

  • C12M25/00Primary

    Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9587213B2 cover?
Molds for making cell aggregation devices include upper and lower surfaces. Methods of aggregating cells include depositing cells on in a seeding chamber, incubating the cells and removing aggregated cells. Devices for encapsulating aggregates of cells include biocompatible, bio-sustainable substrates compartments and a coating of a biocompatible, bio-sustainable polymer that completely surroun…
Who is the assignee on this patent?
Univ Brown
What technology area does this patent fall under?
Primary CPC classification C12N5/0012. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).